| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| 09/22/2005 | US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/22/2005 | US20050209329 Potentiation of therapeutic effects of fatty acids |
| 09/22/2005 | US20050209273 Neuroprotectants, analgesics or anticonvulsants |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209213 Quinoline compound |
| 09/22/2005 | US20050209207 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery |
| 09/22/2005 | US20050209151 Administering a ligand peptide for a G protein-coupled receptor protein for regulating the secretion of corticotropin-releasing hormones; hypoaldosteronism, hypocortisolemia, secondary or chronic hypoadrenocorticism, Addison's disease, adrenal dysfunction, or obesity |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | CA2559444A1 Imidazopyridazine diones, the production thereof, and the use of the same as a medicament |
| 09/21/2005 | EP1577288A1 Selective estrogen receptor modulators |
| 09/21/2005 | EP1576088A2 Dominant negative proteins and methods thereof |
| 09/21/2005 | EP1575942A1 Novel compounds having selective inhibiting efect at gsk3 |
| 09/21/2005 | EP1575939A1 Novel compounds having selective inhibiting effect at gsk3 |
| 09/21/2005 | EP1575938A1 Novel compounds having selective inhibiting effect at gsk3 |
| 09/21/2005 | EP1575524A2 Proliferated cell lines and uses thereof |
| 09/21/2005 | EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 09/21/2005 | EP1438038A4 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 09/21/2005 | EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use |
| 09/21/2005 | EP1042325B1 Nitrogen-containing heterocyclic compounds, their production and use |
| 09/21/2005 | EP0712303B1 Skin patches comprising testosterone and optionally estrogen |
| 09/21/2005 | CN1671863A Central airway administration for systemic delivery of therapeutics |
| 09/21/2005 | CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/21/2005 | CN1671696A 激酶抑制剂 Kinase inhibitors |
| 09/21/2005 | CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders |
| 09/21/2005 | CN1219780C Heterocyclic compounds binding chemotactic factor receptor |
| 09/20/2005 | US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/20/2005 | US6946487 Regulation of intracellular glucocorticoid concentrations |
| 09/20/2005 | US6946464 Methods of treating and preventing a convulsive state |
| 09/20/2005 | US6946454 Thio-oxindole derivatives |
| 09/15/2005 | WO2005085223A1 Composition for prevention and/or treatment of bone disease, functional food or health food containing the composition, and medicinal preparation containing the composition as active ingredient |
| 09/15/2005 | WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient |
| 09/15/2005 | WO2005085200A1 Pyridone derivative |
| 09/15/2005 | WO2005084681A1 Composition for increasing levels of hormones and a method for preparation of said composition |
| 09/15/2005 | WO2005065050A3 Bicyclic compound |
| 09/15/2005 | US20050203103 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/15/2005 | US20050203100 Administering acridin-9-yl-[4-(4-methylpiperazin-1-yl)-phenyl]amine (JP-1302); cognition activators, drug abuse, alcoholism, cigarette smoking cessation, schizophrenia, Tourette*s syndrome, epilepsy, psychosis; sexual, psychological, obsessive-compulsive, or nervous system disorders; psychiatry |
| 09/15/2005 | US20050202101 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 09/15/2005 | US20050202072 Dry mouldable drug formulation |
| 09/15/2005 | US20050201986 Cell targeting compositions and methods of using the same |
| 09/14/2005 | EP1574212A1 Prevention and treatment of androgen-deprivation induced hot flashes, decreased lean muscle mass, loss of libido or erectile dysfunction |
| 09/14/2005 | EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 09/14/2005 | EP1572885A2 Methods for treating diabetes and other blood sugar disorders |
| 09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
| 09/14/2005 | EP1572877A2 Drug metabolizing enzymes |
| 09/14/2005 | EP1572299A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 09/14/2005 | EP1572230A1 Placental alkaline phosphatase to control diabetes |
| 09/14/2005 | EP1572211A1 Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 09/14/2005 | EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 09/14/2005 | EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders |
| 09/14/2005 | EP1572171A2 Reduction of breast density with 4-hydroxy tamoxifen |
| 09/14/2005 | EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 09/14/2005 | EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives |
| 09/14/2005 | CN1668762A Sgk and Nedd used as diagnostic and therapeutic targets |
| 09/14/2005 | CN1668759A Method of searching substane having antidiabetic activity |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/14/2005 | CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 09/14/2005 | CN1668332A Liquid formulations with a high concentration of human growth hormone (HGH) comprising glycine |
| 09/14/2005 | CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 09/14/2005 | CN1668306A 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-((pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating mutated-RET kinase associated diseases |
| 09/14/2005 | CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/14/2005 | CN1666986A Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use |
| 09/14/2005 | CN1218743C Proprietary Chinese medicine for treating hyperthyroidism |
| 09/14/2005 | CN1218686C Process for preparing birth controller in pessary or uterus |
| 09/13/2005 | US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943162 Osteoporosis; cardiovascular disorders; anticancer agents;incontinence |
| 09/13/2005 | US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds |
| 09/13/2005 | US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity |
| 09/13/2005 | US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse |
| 09/08/2005 | US20050197286 Method for control of depression using c terminal growth hormone (gh) fragment |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1569936A1 Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments |
| 09/07/2005 | EP1569907A1 Nicotinamide-based kinase inhibitors |
| 09/07/2005 | EP1569643A2 Use of peroxisome proliferator activated receptor (ppar)-gamma ligands as a treatment for pituitary tumors and associated conditions, such as cushing's syndrome |
| 09/07/2005 | EP1569636A2 Use of equol for treating androgen mediated diseases |
| 09/07/2005 | EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 09/07/2005 | EP1569628A1 Novel use of lycopene |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 09/07/2005 | EP1013278B1 The extract of pine needle and the use thereof |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
| 09/07/2005 | CN1665541A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665540A Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665516A Infertility treatment with exemestane |
| 09/07/2005 | CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1663561A Use of rare earth element salt in preparation of insulin beta cell for treating diabetes |
| 09/07/2005 | CN1217945C CRF receptor antagonists and methods relating thereto |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |